Experts Predict Booming E-Cigarette Industry by 2023

Dec.30.2022
Experts Predict Booming E-Cigarette Industry by 2023
The electronic cigarette industry is expected to thrive in the coming 2 years, with the Republican-controlled House of Representatives.

Experts in the US House of Representatives predict that the electronic cigarette industry will thrive in 2023.


In late November, experts in the electronic cigarette industry shared their overall outlook for the future two years after the 2022 elections for the Vapor Technology Association (VTA). They believe that the next two years will be better than the previous two years.


Tony Abboud, the executive director of the Vapor Technology Association, revealed that his organization has been collaborating with two lobbying groups based in Washington D.C., West Front Strategies and public affairs firm FORA Partners, to advance American interests. He also stated that the e-cigarette industry will continue to develop as the Republican Party takes control of the U.S. House of Representatives in 2023. "We have a very specific agenda, and we have discussed some of it as an overview of what we are pursuing," he said. "We have done a lot of groundwork.


Shimmy Stein, a partner at West Front Strategies, suggests that a change in leadership within the House of Representatives could have a positive impact on the electronic cigarette industry, at least until the next election cycle. "Taking control of messaging, the chairmanship, and the legislative process is a crucial part of governance," he explained. "Therefore, while the House may not have reached the level or size desired by Republicans in terms of the majority seats, it is still very important and will change the way Washington operates.


According to Craig Kalkut, a partner at West Front Strategies, the e-cigarette industry is expected to feel "more comfortable and secure" in the divided Congress over the next two years (with no change in leadership in the U.S. Senate). However, concerns over youth e-cigarette use have posed threats from both Democrats and Republicans. "We still need to work with both sides. We may still face issues and threats of overregulation and inadequate legislation. But most importantly, we will have a more comfortable environment because the Republicans control one House of Congress," Kalkut said.


Kalkut stated that reconciliation is a way for Congress to pass tax, spending, and debt limit legislation with a majority vote, without posing a threat to the e-cigarette industry. He said this is impossible in a divided Congress. "Ultimately, this means that anything that passes needs support from both parties," Kalkut said. "Therefore, [legislation] may be more limited, more moderate, and hopefully, if we pass anything in our region, it will be something that allows us to thrive, addresses concerns around youth vaping, but does not overregulate and push people away from e-cigarettes.


Carl Cutt also confirmed that the deadlock is an issue within a divided Congress; however, it could also prompt compromise between the two sides. "They are both seen as responsible, so sometimes they both want to get something done. This will bring people to the negotiating table, and often it is not an issue at the core of the ideology of either party," he said. "It is difficult to reach an agreement on tax issues, or it is difficult to reach an agreement on healthcare issues, but areas where Democrats and Republicans can come together, such as electronic cigarettes, common sense provisions may have a chance to prevail.


Max Hamel, co-founder of FORA, stated that when Congress is divided, the White House tends to heavily rely on executive privilege. Since there is no known executive agenda regarding e-cigarettes, it is unlikely that any regulations related to them will be implemented. As Republicans control the House of Representatives, they also lead the committees. Hamel said that the House Oversight Committee and its subcommittees could provide opportunities for the e-cigarette industry.


We do have new faces in both the majority and minority, so they may encounter some growing pains," he said. "The biggest issue is how to exercise this new power, especially in the House of Representatives. Whether it's one seat or 40 seats, the power of the majority is the same, and it comes from an oversight and investigative standpoint. From a legislative perspective, it may not necessarily be right. As members of oversight committees, we do have a chance to be in the spotlight, but this is indeed an opportunity for us right now, rather than just defending and focusing on things that benefit us.


In addition, as Juul loses control over the e-cigarette market, Hamel notes that the industry is undergoing a transformation. Juul had been the focus of efforts to protect young people from e-cigarette use, but today it is no longer the main focus. The market is now composed of more diverse companies that have different technologies aimed at reducing harm. Hamel believes this message should be conveyed: "I think our primary task is to focus on information that emphasizes harm reduction," he says.


Kalkut added that the e-cigarette industry now has an opportunity to change the conversation, particularly with Democratic and Republican critics and skeptics, by continuously expanding the scientific evidence that shows the relative safety and huge potential for harm reduction of the next generation of e-cigarette products compared to tobacco products. "As the past few years have gone by, this has become increasingly clear," he said. "I believe that once we prove this point, once we demonstrate that we as an industry association are committed to addressing youth e-cigarette use, we have a real opportunity to change this narrative.


Ashley Davis, co-founder of West Front Strategies, told attendees that in retrospect, the industry has overcome challenges and achieved success. However, she expressed concerns prior to the previous session of Congress (2020-2022) as to which direction or to what extent the electronic cigarette industry would be relied upon by the Biden administration. She stated that the industry "dodged a bullet" and may have faced even greater losses in the first two years of the Biden administration. She also noted that the issue of youth usage will continue to be a primary concern in any discussion of products that deliver electronic nicotine delivery systems.


We do need to address the youth issue and I think we all recognize that any negative news that arises is usually centered around it...Everyone likes a microphone. It's a congressman thing. If there's an issue to be discussed, that's what they're going to discuss," explained Davis. "[We are] working to ensure that no bad legislation is passed - which is less likely in this Congress than ever before.


Abboud fielded questions from the audience and concluded the conference by speculating about the potential impact of the Reagan-Udall Foundation's external review of the U.S. Food and Drug Administration's Tobacco Products Center. He predicted that the results of the review would be announced in mid-December.


According to Abboud, the large number of comments from FDA staff regarding the Reagan-Udall evaluation indicates that the regulatory agency is in disarray and influenced more by external forces rather than scientific research. He expressed his hope that the foundation would recommend to the FDA that the decision for pre-market tobacco product applications (PMTA) should not be subject to any external pressure, especially political pressure.


Abboud stated that the review process should adhere to FDA recommendations that PMTAs must be determined based on the science submitted, and ensure that the agency actually reviews all the science submitted as part of any application and reviews all submitted applications. He added that this is another significant failure of the current process, where applications are being rejected without comprehensive review.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

PMI Launches Fourth IQOS Convenience-Store Discount of 2026 for Black Friday in Japan, Cutting ILUMA i ONE to About $19 After Ploom AURA Fell to About $9
PMI Launches Fourth IQOS Convenience-Store Discount of 2026 for Black Friday in Japan, Cutting ILUMA i ONE to About $19 After Ploom AURA Fell to About $9
Philip Morris Japan launched its fourth confirmed nationwide convenience-store discount campaign for IQOS ILUMA i devices in 2026 on October 26, cutting three models by as much as ¥2,000, or about $12.70. The campaign began one day after JT ended a promotion that reduced Ploom AURA to ¥1,480, or about $9.40. JT says Ploom's share of Japan's heated-products category rose from 10.9% in January 2024 to 18.3% in June 2026, a gain of 7.4 percentage points, while PMI says IQOS still held about 68% category share in the third quarter. At the same time, Japan's two-stage heated-tobacco tax adjustment has pushed stick prices higher, leaving device discounts as an increasingly important tool for lowering the upfront cost of customer acquisition.
Market
Oct.28
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives
NATO Executive Director David Spross Sees U.S. Vape Regulation Improving, Calls for More PMTA Authorizations and Warns of 2027 State Tax Pressure
NATO Executive Director David Spross Sees U.S. Vape Regulation Improving, Calls for More PMTA Authorizations and Warns of 2027 State Tax Pressure
The National Association of Tobacco Outlets is calling for more FDA marketing authorizations, greater transparency in the PMTA process and continued enforcement against unauthorized e-cigarettes, even as its executive director, David Spross, points to recent regulatory developments as signs of progress. At the state level, excise taxes, flavor restrictions and vapor product directories remain major issues for tobacco retailers. By August 2026, 17 states had enacted laws establishing state-managed e-cigarette directories or similar systems.
Innovation
Sep.29 by 2Firsts Perspectives
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Product | Philip Morris Korea Launches Two TEREA ONYX Capsule Tobacco Sticks, Expanding Portfolio to Five Lines
Philip Morris Korea launched TEREA ONYX, a new tobacco stick line for IQOS ILUMA devices, on October 15, 2026. The initial products, AMANG PEARL and CALI PEARL, feature tropical-inspired flavors, Fresh Filters and capsules designed to deliver different flavor experiences before and after activation. Both are priced at KRW 4,800 per pack and are available at convenience stores nationwide and IQOS-operated stores in South Korea. The launch expands the Korean TEREA portfolio from four product lines to five, following earlier capsule tobacco stick additions in 2026.
product
Oct.23
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives